We’re heading towards a scenario where multidrug-resistant bacteria is set to kill more people a year than cancer. It’s time to prioritise comprehensive and optimal antibiotic treatment.

In this engrossing episode of High Potential Start-Ups, Nick Ross, Co-Founder of https://www.linkedin.com/in/cavenaghhealth/ (Cavenagh Health), is joined by Neciah Dorh.

Neciah is Co-Founder and CEO of FluoretiQ Limited, a Bristol-based start-up addressing the need for rapid tools to detect and identify bacteria in patient samples.

They discuss the scale of the challenge we’re facing, how FluoretiQ’s solution is different, and what it takes to start and run a business made up of a diverse team.

Get in touch with https://www.linkedin.com/in/ndorh/ (Neciah).

Get in touch with https://www.linkedin.com/in/cavenaghhealth/ (Nick).